Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Curr Drug Saf ; 19(2): 295-298, 2024.
Article En | MEDLINE | ID: mdl-37231731

INTRODUCTION: Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are severe adverse drug reactions characterized by widespread blistering and mucositis. Wilson's disease is a rare, autosomal recessive disorder that results in excessive copper accumulation in the body, where penicillamine is an effective treatment option for copper chelation. Penicillamineinduced SJS-TEN is a rare but potentially fatal adverse effect. There is increased susceptibility to SJS/TEN in HIV infection due to immunosuppression and chronic liver disease due to impaired hepatic function. OBJECTIVE: To diagnose and manage the occurrence of the rare severe adverse cutaneous drug reactions in the backdrop of immunosuppression and chronic liver disease. CASE REPORT: We are reporting penicillamine-induced SJS-TEN overlap in a 30-year-old male with Wilson's disease, HIV and Hepatitis B who was treated with intravenous immunoglobulins. The patient later developed neurotrophic ulcer in the right cornea as a delayed sequela. CONCLUSION: Our case report emphasizes that there is an increased predisposition to SJS/TEN in immunocompromised and chronic liver disease patients. Physicians should be well aware of the potential danger of SJS/TEN in this subset of patients, even while prescribing a relatively safer drug.


HIV Infections , Hepatitis B , Hepatolenticular Degeneration , Stevens-Johnson Syndrome , Male , Humans , Adult , Stevens-Johnson Syndrome/diagnosis , Stevens-Johnson Syndrome/etiology , Stevens-Johnson Syndrome/drug therapy , Penicillamine/adverse effects , Hepatolenticular Degeneration/diagnosis , Hepatolenticular Degeneration/drug therapy , Copper/therapeutic use , HIV Infections/complications , HIV Infections/drug therapy , Hepatitis B/complications , Hepatitis B/diagnosis , Hepatitis B/drug therapy
...